Related references
Note: Only part of the references are listed.
Review
Oncology
Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer
Xavier Ghislain Leon Victor Pouwels et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Review
Health Care Sciences & Services
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
Carlo Lazzaro et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2013)
Share Paper
